Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous KIT/PDGFRA Mutations in the Phase III INVICTUS Study https://t.co/Mty0sHeOF4 #hvhebron #onco [Text complet]
2,358 followers
36 followers
RT @CCR_AACR: Phase 3 Study: Efficacy of ripretinib against range of KIT/PDGFRA mutations (INVICTUS Study). https://t.co/GzmkYVvyue https:/…
584 followers
RT @CCR_AACR: Phase 3 Study: Efficacy of ripretinib against range of KIT/PDGFRA mutations (INVICTUS Study). https://t.co/GzmkYVvyue https:/…
111 followers
RT @CCR_AACR: Phase 3 Study: Efficacy of ripretinib against range of KIT/PDGFRA mutations (INVICTUS Study). https://t.co/GzmkYVvyue https:/…